Henry Richard CHIJCHEAPAZA-FLORES

Mr. Henry Richard CHIJCHEAPAZA-FLORES

Univ. Lille, INSERM, CHU Lille, U1008 - Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
FBFlorent Barry
Florent Barry
FCFeng Chai
Feng Chai
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
MFMaria-Jose Garcia Fernandez
Maria-Jose Garcia Fernandez
NBNicolas Blanchemain
Nicolas Blanchemain
RNRomain Nicot
Romain Nicot

22 March 2023 in Gels
Verified
Journal Article
Open access
PDF file
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
NTNicolas Tabary
Nicolas Tabary
FCFeng CHAI
Feng CHAI
MMMickaël Maton
Mickaël Maton
Jean-Noël STAELENSJean-Noël STAELENS
Jean-Noël STAELENS
MFMaria-Jose Garcia Fernandez
Maria-Jose Garcia Fernandez
Diabetic foot ulcers (DFU) are among the most common complications in diabetic patients and affect 6.8% of people worldwide. Challenges in the management of this disease are decreased blood diffusion, sclerotic tissues, infection, and antibiotic resistance. Hydrogels are now being used as a new treatment option since they can be used for drug delivery and to improve wound healing. This project aims to combine the properties of hydrogels based on chitosan (CHT) and the polymer of β cyclodextrin (PCD) for local delivery of cinnamaldehyde (CN) in diabetic foot ulcers. This work consisted of the development and characterisation of the hydrogel, the evaluation of the CN release kinetics and cell viability (on a MC3T3 pre-osteoblast cell line), and the evaluation of the antimicrobial and antibiofilm activity (S. aureus and P. aeruginosa). The results demonstrated the successful development of a cytocompatible (ISO 10993-5) injectable hydrogel with antibacterial (99.99% bacterial reduction) and antibiofilm activity. Furthermore, a partial active molecule release and an increase in hydrogel elasticity were observed in the presence of CN. This leads us to hypothesise that a reaction between CHT and CN (a Schiff base) can occur and that CN could act as a physical crosslinker, thus improving the viscoelastic properties of the hydrogel and limiting CN release.

1 August 2021 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
RNRomain Nicot
Romain Nicot
FBFlorent Barry
Florent Barry
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
MGMaria José Garcia-Fernandez
Maria José Garcia-Fernandez
GRGwénaël Raoul
Gwénaël Raoul
FCFeng Chai
Feng Chai

1 April 2023 in Toxins
Verified
Journal Article
Open access
PDF file
MBMarie Béret
Marie Béret
FBFlorent Barry
Florent Barry
MFMaria-Jose Garcia Fernandez
Maria-Jose Garcia Fernandez
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
NBNicolas Blanchemain
Nicolas Blanchemain
RNRomain Nicot
Romain Nicot
Temporomandibular disorders (TMD) are complex pathologies responsible for chronic orofacial pain. Intramuscular injection of botulinum toxin A (BoNT/A) has shown effectiveness in knee and shoulder osteoarthritis, as well as in some TMDs such as masticatory myofascial pain, but its use remains controversial. This study aimed to evaluate the effect of intra-articular BoNT/A injection in an animal model of temporomandibular joint osteoarthritis. A rat model of temporomandibular osteoarthritis was used to compare the effects of intra-articular injection of BoNT/A, placebo (saline), and hyaluronic acid (HA). Efficacy was compared by pain assessment (head withdrawal test), histological analysis, and imaging performed in each group at different time points until day 30. Compared with the rats receiving placebo, those receiving intra-articular BoNT/A and HA had a significant decrease in pain at day 14. The analgesic effect of BoNT/A was evident as early as day 7, and lasted until day 21. Histological and radiographic analyses showed decrease in joint inflammation in the BoNT/A and HA groups. The osteoarthritis histological score at day 30 was significantly lower in the BoNT/A group than in the other two groups (p = 0.016). Intra-articular injection of BoNT/A appeared to reduce pain and inflammation in experimentally induced temporomandibular osteoarthritis in rats.

5 November 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
KSKadiatou SY
Kadiatou SY
Kevimy AGOSSAKevimy AGOSSA
Kevimy AGOSSA
MMMickaël Maton
Mickaël Maton
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
BMBernard Martel
Bernard Martel
CNChristel Neut
Christel Neut
The aim of our study was to explore the potential value of metallic (Ag, Cu, and Zn) salts, polymer/metallic nanoparticles, and chlorhexidine (CHX) for improving the antimicrobial activity of calcium hydroxide (CH) against E. faecalis and C. albicans, associated with persistent endodontic infections. A first screening was performed by determining minimum inhibitory/bactericidal concentrations (MIC/MBC). Antimicrobial activity of the CH paste mixed with metallic salts, chitosan or cyclodextrin polymer metallic nanoparticles was compared to the antimicrobial activity of CH paste alone and CH + CHX using a time-kill kinetics assay. The effect of the antimicrobials on the rheological and the key mechanical properties were also examined. Copper and zinc were discarded because of their MIC/MBC values and silver because of its kill time curve profile. Except for a slower setting time after 24 h and a higher weight loss after 1 week of incubation, the mechanical behavior of the CH paste was unaffected by the addition of CHX. Polymeric/metallic nanoparticles failed to potentiate the antimicrobial effect of CH. By contrast, CHX increased this effect and thus could help eradicate E. faecalis associated with persistent root canal infections without altering the desired key physical properties of the CH paste.

31 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FBFlorent Barry
Florent Barry
FCFeng Chai
Feng Chai
HCHenry Richard CHIJCHEAPAZA-FLORES
Henry Richard CHIJCHEAPAZA-FLORES
MGMaria José Garcia-Fernandez
Maria José Garcia-Fernandez
NBNicolas Blanchemain
Nicolas Blanchemain
RNRomain Nicot
Romain Nicot
To compare two agents that can induce a rat model of temporomandibular joint osteoarthritis (TMJOA) by chemical induction: monosodium iodoacetate (MIA) and collagenase type 2 (Col-2). We wished to ascertain the best agent for assessing drug-delivery systems (DDSs). Male Wistar rats underwent intra-articular injection with MIA or Col-2. They were manipulated for 30 days. The head withdrawal threshold (HWT), immunohistological assessment, and positron emission tomography (PET) were used to evaluate the relevance of our models. For both the MIA and Col-2 groups, pain persisted for 30 days after injection. Change in the HWT showed that Col-2 elicited a strong action initially that decreased progressively. MIA had a constant action upon pain behavior. Histology of TMJ tissue from both groups showed progressive degradation of TMJ components. MIA and Col-2 induced orofacial pain by their local chemical action on TMJs. However, based on a prolonged and greater sustained effect on the pain threshold, persistent histological changes, and imaging results, MIA appeared to be more suitable for creation of a rat model of TMJOA for the study of DDSs.